90
Participants
Start Date
February 1, 2023
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
Sound sparing levonorgestrel 52 mg IUD placement
"In phase one, the IUD will be placed in a standard fashion with the use of a uterine sound to obtain baseline data.~In the experimental phases of the study (phase 2 and 3) the levonorgestrel 52 mg IUD will be placed without the use of a uterine sound. In phase 2 the IUD will be placed under abdominal ultrasound guidance. In phase 3 the IUD will be placed without abdominal ultrasound guidance."
University of California Davis, Sacramento
University of California, Davis
OTHER